Abstract
Oxaliplatin is a platinum-based chemotherapeutic used to treat gastrointestinal malignancies,1 infused every 2 weeks often in combination with leuvocorin and 5-fluorouracil (FOLFOX). Significant adverse events, including hypersensitivity reactions, are noted with oxaliplatin use. Desensitization has proven safety and efficacy for oxaliplatin hypersensitivity reactions.2,3
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
